An interventional study of Acupuncture and Healthy education in Abdominal Obesity and Metabolic Syndrome, sponsored by Dongfang Hospital Beijing University of Chinese Medicine. Completed at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-08-17.
Sponsored by Dongfang Hospital Beijing University of Chinese Medicine · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Obesity, Abdominal with a site in China — 6 open to participants now, 7 under way, 1 of them phase 3. Obesity, Abdominal · China.
Among the 19 studies in Obesity, Abdominal with a site in China, this one is the 9th largest by enrollment of the 17 interventional ones that give a count, is the only one that started in 2014, is one of 12 with no phase, and was the 3rd registered.
295 studies on the registry are indexed under Obesity, Abdominal; 45 are open to participants now.
Browse Obesity, Abdominal studies →6 of the 19 studies in Obesity, Abdominal with a site in China are open now. Recruiting first, the newest first:
Amway (China) R&D Center · Sites in China
Ages 30–65 · Healthy volunteers
Eli Lilly and Company · Sites in China, United States, Argentina and 9 more countries
Ages 18+
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Sites in China
Ages 18–64
RenJi Hospital · Sites in China
Ages 18–65
Chinese University of Hong Kong · Sites in China
Ages 18–65
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 26 Obesity, Abdominal studies recruiting now, 3 (12%) set no upper age limit and 21 (81%) stop at 75 or younger; 1 takes children under 18; 10 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 120 is above the median of 58 across 235 interventional studies indexed under Obesity, Abdominal.
Median enrollment 120 across the 17 interventional studies, 211 across the 2 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 19 have an industry lead sponsor. The 10 most frequent:
Dongfang Hospital Beijing University of Chinese Medicine is the lead sponsor of 10 studies on the registry; none are open to participants now.
Dongfang Hospital Beijing University of Chinese Medicine has 2 studies filed under Obesity, Abdominal — fewer than ten, so there is no comparison to draw.
4 of the studies in Obesity, Abdominal with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05749874China National Center for Cardiovascular DiseasesEffects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus | 2026-12-31 |
| NCT07924956Amway (China) R&D CenterExplore the Weight Loss Effect of Amway "BODY TRIMMER" | 2027-02 |
| NCT06359418Guang'anmen Hospital of China Academy of Chinese Medical SciencesAcupuncture for Prediabetes With Combined Obesity | 2027-06-01 |
| NCT07759323Zhejiang Provincial Tongde HospitalPolygonatum Sibiricum Reduces Visceral Fat in Obese Adults | 2027-07-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 19 studies in Obesity, Abdominal with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To evaluate the effectiveness of acupuncture therapy combined with healthy education for patients with abdominal obesity.
This subject is a prospective, single-blind, parallel-group, randomized controlled clinical trial.120 patients with abdominal obesity are allocated into two groups with a ratio of 2:1.Randomized series was generated by computer. The allocation was concealed. Patients in the intervention group are received acupuncture therapy and healthy education. Patients in the control group are only given healthy education. The treatment in both intervention group and control group lasts for 8 weeks. Comparison of two groups of patients with abdominal fat thickness, fasting serum visfatin concentration, simple anthropometric parameters (including body weight, body mass index, waist circumference, hip circumference, waist-to-hip radio, waist-to-height radio, the percentage of body fat), fasting blood glucose, fasting insulin, glycosylated hemoglobin, fasting blood lipid (total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein), uric acid, blood pressure, insulin resistance level, and obesity related lifestyle survey.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention including acupuncture treatment and healthy education.
Other: Acupuncture · Other: Healthy education
Healthy education is given as a baseline treatment.
Other: Healthy education
Acupuncture needles of 0.3mm in diameter and 100mm in length are inserted into gallbladder-meridian(GB)26 about 25-65mm deep by an angle of 15°, following the path of Dai Meridian (towards medial and downside) . The other acupoints are inserted with needles of 0.25-0.3mm in diameter and 25-40mm in length approximately 10-30mm deep, with an angle of 90°. Electro-acupuncture is applied to both sides of GB26 and stomach-meridian(ST)25: cathode is connected to GB26; anode to ST25. Dense-disperse wave pattern and a wave frequency of 2/100 Hertz is chosen. The intensity of the electro-acupuncture is adjusted on average 4-8 milliampere. The needles are subsequently retained for 20min. The results of the study are based on 8 weeks, each week consisting of 3 sessions.
Healthy knowledge lectures and issuing brochures are given. Education of patients for conditioning and changing bad habits, diet, quit smoking, limit alcohol consumption, salt restriction, appropriate increase in physical activity.
Changes from Baseline in abdominal subcutaneous fat thickness at 8 weeks
Including subcutaneous fat thickness 1 and 2
Time frame: baseline and 8 weeks
Changes from Baseline in abdominal visceral fat thickness at 8 weeks
Including visceral fat thickness 1 and 2
Time frame: baseline and 8 weeks
Change from Baseline in antero-hepatic fat thickness at 8 weeks
Antero-hepatic fat thickness (AHF) was determined by the distance of peritoneum to the hepatic cortex at the subcostal level.
Time frame: baseline and 8 weeks
Change from Baseline in perirenal fat thickness at 8 weeks
Perirenal fat thickness (PRF) was determined by the thickest one of the perirenal fat capsule of the right kidney short axis, when the right renal short axis and the maximum width of the renal sinus were clearly displayed.
Time frame: baseline and 8 weeks
Change from Baseline in ultrasound viscerofatty index at 8 weeks
ultrasound viscerofatty index (UVI) = (visceral fat thickness 1 + visceral fat thickness2)/(subcutaneous fat thickness 1 + subcutaneous fat thickness 2)
Time frame: baseline and 8 weeks
Change from Baseline in fasting serum visfatin at 8 weeks
5ml venous blood was told after an 8 hours fast. Visfatin was measured by enzyme-linkedimmuno sorbent assay (ELISA).
Time frame: baseline and 8 weeks
Change from Baseline in body weight
It's made at the situation of fasting, after emptying bowels, with minimal clothing, without headdress and footwear, at the end of expiration.
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in body mass index
Body mass index (BMI) = body weight(kg)/height(m)/height(m)
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in waist circumference
WC was measured at the level between the inferior portion of 12th rib and iliac crest.
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in hip circumference
HC was measured at the level of the most prominent point of the pelvis.
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in waist-to-hip radio
waist-to-hip radio (WHR) = waist circumference(cm)/hip circumference(cm)
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in waist-to-height radio
waist-to-height radio (WHtR) = waist circumference(cm)/height(cm)
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in the percentage of body fat
the percentage of body fat = 1.2×BMI+0.23×age-5.4-10.8×gender(M=1,F=0)
Time frame: baseline, 4 weeks and 8 weeks
Change from Baseline in fasting blood glucose at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting insulin at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in glycosylated hemoglobin at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting total cholesterol at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting triglyceride at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting high density lipoprotein cholesterol at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting low density lipoprotein cholesterol at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in fasting uric acid at 8 weeks
5ml venous blood was collected after an 8 hours fast. It was tested by our hospital's laboratory.
Time frame: baseline and 8 weeks
Change from Baseline in blood pressure at 8 weeks
Time frame: baseline and 8 weeks
Change from Baseline in insulin resistance level at 8 weeks
Time frame: baseline and 8 weeks
Change from Baseline in obesity related lifestyle survey at 8 weeks
Time frame: baseline and 8 weeks
The record gives a start of Jun 2014, a primary completion of Apr 2015 and a completion of Sep 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dongfang Hospital Beijing University of Chinese Medicine